logo
ESE Q1 Earnings Call: Maritime Acquisition Drives Growth Outlook, Margins Expand Across Segments

ESE Q1 Earnings Call: Maritime Acquisition Drives Growth Outlook, Margins Expand Across Segments

Yahoo12-06-2025
Engineered products manufacturer ESCO (NYSE:ESE) met Wall Street's revenue expectations in Q1 CY2025, with sales up 6.6% year on year to $265.5 million. The company's full-year revenue guidance of $1.2 billion at the midpoint came in 4.5% above analysts' estimates. Its non-GAAP profit of $1.35 per share was 8.3% above analysts' consensus estimates.
Is now the time to buy ESE? Find out in our full research report (it's free).
Revenue: $265.5 million vs analyst estimates of $266.4 million (6.6% year-on-year growth, in line)
Adjusted EPS: $1.35 vs analyst estimates of $1.25 (8.3% beat)
Adjusted EBITDA: $56.67 million vs analyst estimates of $54.29 million (21.3% margin, 4.4% beat)
Management raised its full-year Adjusted EPS guidance to $6 at the midpoint, a 6.2% increase
Operating Margin: 16.2%, up from 13.3% in the same quarter last year
Backlog: $932.3 million at quarter end
Market Capitalization: $4.75 billion
ESCO'S first quarter results were shaped by improved operational performance across all three of its business segments, with management highlighting order acceleration and favorable product mix as key contributors. CEO Bryan Sayler emphasized the stabilization and recovery in the test segment, citing increased activity in electromagnetic compatibility, healthcare, and industrial end-markets. The utility group benefited from healthy demand in electricity infrastructure, while aerospace and defense growth was supported by increased Navy orders and commercial aerospace recovery. CFO Chris Tucker noted that incremental margins were driven by price increases, particularly in commercial aerospace, and better mix in both the utility and test businesses. Recent operational challenges in specific product lines, such as those discussed in prior years, were described as largely resolved, contributing to the margin expansion experienced this quarter.
Looking ahead, ESCO's updated full-year adjusted EPS guidance—now an all-in range of $5.85 to $6.15 per share, which incorporates an increase in the base business outlook to $5.65-$5.85 per share and an estimated $0.20 to $0.30 per share from the recent ESCO Maritime Solutions acquisition—and its strategic priorities signal management's confidence in continued growth. CEO Bryan Sayler pointed to favorable end-market exposure in defense and utilities, noting, 'We feel strongly that our end market exposure remains favorable, and growth tailwinds should persist as we move forward.' Management is watching tariff impacts closely but believes mitigation efforts—including pricing adjustments and operational shifts—should limit the net effect. CFO Chris Tucker added that the maritime acquisition is trending at or above original projections and is expected to enhance both growth and margin profile. However, Sayler acknowledged that macroeconomic uncertainties and evolving trade policies could create headwinds, particularly if retaliatory actions emerge, but the company believes its diverse business mix provides resilience.
Management attributed the quarter's improved profitability to favorable business mix, successful price actions, and the initial contribution from the newly acquired maritime business.
Maritime Solutions acquisition completed: The closing of ESCO Maritime Solutions (formerly SM&P) was highlighted as a major strategic milestone that strengthens the company's margin and growth profile. Management stated the business is performing at or above original expectations, providing immediate contribution to both sales and adjusted earnings.
Aerospace and defense margin expansion: Growth in Navy and commercial aerospace orders drove higher margins, supported by favorable program and customer mix. Price increases in commercial aerospace began to flow through, with CFO Chris Tucker noting, 'We're starting to see some of that really helping us and coming through nicely.'
Utility group's product mix shift: The utility segment benefited from double-digit order growth at Doble, and margin gains were attributed to a shift toward higher-margin legacy offline testing products. NRG, another utility business, stabilized after prior declines, contributing to overall profitability.
Test segment recovery: The test business saw a broad-based recovery in order activity, with strong demand in electromagnetic compatibility (EMC) testing, healthcare (notably magnet swaps in hospitals), and industrial applications like electromagnetic pulse (EMP) filters for data centers and utilities. Management described this as a trend likely to persist.
Tariffs and trade risk mitigation: Management proactively included estimated tariff impacts in its outlook, with mitigation measures such as pricing actions and operational adjustments expected to offset some of the exposure. The company remains more of a net exporter, and broader risks are seen as demand-related if global trade tensions escalate.
ESCO's full-year outlook is driven by the integration of the maritime acquisition, ongoing demand in defense and utility markets, and efforts to counteract tariff-related headwinds.
Maritime Solutions integration: The addition of ESCO Maritime Solutions is expected to enhance both top-line growth and profit margins, with management projecting that the business will continue to outperform initial assumptions. Visibility into U.S. and Royal Navy programs provides confidence in sustained demand and healthy backlogs.
End-market momentum in utilities and defense: Management anticipates stable growth in electricity infrastructure (driven by grid modernization, aging infrastructure, and extreme weather) and continued strength in prioritized defense programs, particularly submarines. Exposure to top Department of Defense priorities is expected to ensure funding stability.
Tariff and macroeconomic uncertainties: While management has factored in estimated tariff costs, they are monitoring for potential retaliatory actions and slower demand in certain export markets. Actions such as price adjustments and operational flexibility are in place to help mitigate these risks, but broader economic shifts remain a possible headwind.
Looking ahead, our analysts will be monitoring (1) the successful integration and ongoing performance of ESCO Maritime Solutions, particularly its contribution to margins and backlog; (2) order and sales momentum in the utility and test segments, especially as infrastructure investments and healthcare upgrades continue; and (3) management's effectiveness in offsetting tariff impacts through pricing and operational adjustments. Progress on the potential sale of VACCO and stability in defense funding will also be key indicators to watch.
ESCO currently trades at a forward P/E ratio of 29.7×. At this valuation, is it a buy or sell post earnings? See for yourself in our full research report (it's free).
Donald Trump's victory in the 2024 U.S. Presidential Election sent major indices to all-time highs, but stocks have retraced as investors debate the health of the economy and the potential impact of tariffs.
While this leaves much uncertainty around 2025, a few companies are poised for long-term gains regardless of the political or macroeconomic climate, like our Top 6 Stocks for this week. This is a curated list of our High Quality stocks that have generated a market-beating return of 183% over the last five years (as of March 31st 2025).
Stocks that made our list in 2020 include now familiar names such as Nvidia (+1,545% between March 2020 and March 2025) as well as under-the-radar businesses like the once-micro-cap company Kadant (+351% five-year return). Find your next big winner with StockStory today.
Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

Viking Therapeutics stock falls 37% on high dropout rate in obesity trial
Viking Therapeutics stock falls 37% on high dropout rate in obesity trial

Yahoo

time44 minutes ago

  • Yahoo

Viking Therapeutics stock falls 37% on high dropout rate in obesity trial

-- Viking Therapeutics (NASDAQ:VKTX) stock plunged as much as 37% Tuesday after revealing results from its Phase 2 VENTURE-Oral Dosing trial for its oral obesity treatment, while Eli Lilly (NYSE:LLY) shares gained 1.5% as analysts pointed to competitive advantages. The trial demonstrated that Viking's oral tablet formulation of VK2735, a dual GLP-1 and GIP receptor agonist, met its primary endpoint with patients losing up to 12.2% of body weight after 13 weeks compared to 1.3% for placebo. Despite the weight loss efficacy, the 28% treatment discontinuation rate among patients receiving VK2735 versus 18% for placebo raised significant concerns among investors and analysts. Mizuho analyst Jared Holz highlighted competitive disadvantages compared to Eli Lilly's offerings: "Data look inferior to LLY on almost all metrics and the thing to consider here is that patients discontinued at such a high rate over 13-weeks vs. LLY in the mid 20% range --- but over 72-weeks; A much longer trial, and therefor LLY looks far better head-to-head. This probably shutters hope for VKTX a bigtime player in the oral obesity market over the near to medium term." JPMorgan (NYSE:JPM) analyst Hardik Parikh offered a more balanced view, noting, "In 13 weeks, the three highest-dosing arms of 60/90/120mg showed avg pbo-adj weight loss of ~7.5%, 10%, 11%, which we think is very strong compared with other orals in development. Tolerability overall was manageable, but it was worse than we expected based on the ph1 performance." Parikh added that while the adverse event profile wasn't as clean as in Phase 1 trials, "we still think oral vk-2735 offers strong efficacy with a manageable tolerability profile." Viking reported that 99% of gastrointestinal-related adverse events were mild or moderate. The company also highlighted an exploratory maintenance dosing arm showing weight loss could be maintained at lower doses. The major adverse events included vomiting rates of 20-35% in the three highest dose arms compared to about 10% for placebo, and nausea rates of approximately 58% for patients on treatment versus 48% for placebo. Related articles Viking Therapeutics stock falls 37% on high dropout rate in obesity trial Tesla robotaxi trial impresses, pricing power clear: William Blair Palo Alto Networks gains after strong earnings and Bank of America upgrade

2 Growth Stocks to Buy With $200 and Hold Forever
2 Growth Stocks to Buy With $200 and Hold Forever

Yahoo

timean hour ago

  • Yahoo

2 Growth Stocks to Buy With $200 and Hold Forever

Key Points Unity is in the middle of a turnaround, and growth is just around the corner. AMD is winning market share and building a massive artificial intelligence (AI) chip business. Both growth stocks are under $200 per share. 10 stocks we like better than Unity Software › You don't need much money at all to invest in some of the best growth stocks available. If you've got $200 and are ready to put it to work in the stock market, Unity Software (NYSE: U) and Advanced Micro Devices (NASDAQ: AMD) look like solid bets. Unity is on the cusp of a return to growth, and AMD is stealing market share from its biggest rival. 1. Unity Software: Staging a comeback Video game engine developer Unity has reached an inflection point, according to CEO Matthew Bromberg. The company's accelerated pace of development, its work to regain trust after the Runtime Fee debacle, and its artificial intelligence (AI)-powered Vector ad platform have brought the company close to a return to growth. Overall revenue was still down slightly in the second quarter, but things are moving in the right direction. Unity's Create Solutions segment, which includes its game engine, grew revenue in the second quarter, thanks to a large customer win and an increase in subscription revenue. The Grow Solutions segment, which focuses on advertising, shrank slightly. However, Unity Ad Network grew revenue by 15% compared to the first quarter, thanks to the new Vector platform, which was offset by weakness in other areas. In the third quarter, Unity expects its Grow Solutions segment to report mid-single-digit revenue growth compared to the second quarter, a sign the Vector platform is gaining traction. Create Solutions will be weaker due to the large customer win in the second quarter that won't be repeated. Overall revenue is expected between $440 million and $450 million, up from the second quarter at the midpoint. Unity may not look like much of a growth stock right now, but the company has all the pieces in place to become a long-term winner. The Unity game engine is widely used across the video game industry, and switching costs are significant. On the advertising side, the Vector platform aims to fix issues that have plagued that part of the business for years. As Unity gets back on its feet, now's a great time to buy stock. 2. AMD: A force in CPUs and AI AMD still finds itself in a second-place position behind Intel in the PC and server CPU markets, but the company has gained an incredible amount of ground thanks to good products and Intel's various issues. AMD managed a 27.3% unit share and a 41% revenue share in the server CPU market during the second quarter of 2025. Eight years ago, Intel had a near-monopoly. A similar story has played out in the PC CPU market. AMD managed a 32.2% unit share of the desktop CPU market and a 20.6% unit share of the notebook CPU market, both of which are up dramatically over the past decade. The company's Ryzen CPUs have been winning over consumers as Intel struggled with stability issues for its Raptor Lake chips and later a lackluster launch for Arrow Lake. Outside of CPUs, AMD has built a solid AI accelerator business as well. The company is still far behind market leader Nvidia, but its Instinct data center GPUs are now a multibillion-dollar annual revenue business. The company sees this as a long-term opportunity as AI chip demand continues to explode, with the potential for tens of billions of dollars in annual revenue down the road. AMD faces a few risks. First, Intel under its new CEO could become more aggressive and put pressure on AMD's CPU businesses. Second, if the AI boom starts to fizzle out, the AI accelerator business may not be as lucrative in the long run as the company is assuming. However, even with those risks, AMD is a much stronger company than it was even five years ago, and it should continue to thrive in the years ahead. Do the experts think Unity Software is a buy right now? The Motley Fool's expert analyst team, drawing on years of investing experience and deep analysis of thousands of stocks, leverages our proprietary Moneyball AI investing database to uncover top opportunities. They've just revealed their to buy now — did Unity Software make the list? When our Stock Advisor analyst team has a stock recommendation, it can pay to listen. After all, Stock Advisor's total average return is up 1,070% vs. just 184% for the S&P — that is beating the market by 885.55%!* Imagine if you were a Stock Advisor member when Netflix made this list on December 17, 2004... if you invested $1,000 at the time of our recommendation, you'd have $668,155!* Or when Nvidia made this list on April 15, 2005... if you invested $1,000 at the time of our recommendation, you'd have $1,106,071!* The 10 stocks that made the cut could produce monster returns in the coming years. Don't miss out on the latest top 10 list, available when you join Stock Advisor. See the 10 stocks » *Stock Advisor returns as of August 18, 2025 Timothy Green has positions in Intel. The Motley Fool has positions in and recommends Advanced Micro Devices, Intel, Nvidia, and Unity Software. The Motley Fool recommends the following options: short August 2025 $24 calls on Intel. The Motley Fool has a disclosure policy. 2 Growth Stocks to Buy With $200 and Hold Forever was originally published by The Motley Fool Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data

BNY Mellon Alcentra Global Multi-Strategy Credit Fund, Inc. Announces Details of Liquidation
BNY Mellon Alcentra Global Multi-Strategy Credit Fund, Inc. Announces Details of Liquidation

Business Wire

timean hour ago

  • Business Wire

BNY Mellon Alcentra Global Multi-Strategy Credit Fund, Inc. Announces Details of Liquidation

NEW YORK--(BUSINESS WIRE)-- BNY Mellon Alcentra Global Multi-Strategy Credit Fund, Inc. (Ticker: XALCX) (the "Fund") announced today additional details concerning the liquidation and termination of the Fund. In accordance with the Fund's Charter, the Fund's Board of Directors has approved the termination date of the Fund. The Fund will terminate at the close of business on or about August 29, 2025, approximately the sixth anniversary of the closing date of the Fund's initial public offering (the "Termination Date"). The final NAV is expected to be calculated on the Termination Date with final distributions to be made the week of September 2, 2025. Important Information BNY Mellon Investment Adviser, Inc., the investment adviser for the Fund, is part of BNY Investments. BNY Investments is one of the world's largest asset managers, with $2.1 trillion in assets under management as of June 30, 2025. Through a client-first approach, BNY Investments brings investors specialist expertise through its seven investment firms offering solutions across every major asset class and backed by the breadth and scale of BNY. Additional information on BNY Investments is available on Follow us on LinkedIn for the latest company news and activity. BNY Investments is a division of BNY, which has $55.8 trillion in assets under custody and/or administration as of June 30, 2025. Established in 1784, BNY is America's oldest bank. Today, BNY powers capital markets around the world through comprehensive solutions that help clients manage and service their financial assets throughout the investment life cycle. BNY is the corporate brand of The Bank of New York Mellon Corporation (NYSE: BK). Additional information is available on Follow us on LinkedIn or visit our newsroom for the latest company news. BNY Investments' website is intended to allow investors public access to information regarding the Fund and does not, and is not intended to, incorporate the website in this release.

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into a world of global content with local flavor? Download Daily8 app today from your preferred app store and start exploring.
app-storeplay-store